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Abstract 
Perivascular  epithelioid  cell  tumors
(PEComa) are mesenchymal tumors composed
of  histologically  and  immunohistochemically
distinctive  perivascular  epithelial  cells.
Although the uterine corpus seems to be one of
the  most  prevalent  sites  of  involvement,
PEComa of the uterine cervix are very rare.
Only  four  cervical  PEComa  cases  have  been
described, and were treated with hysterectomy
and radiotherapy. 
We  report  a  case  of  a  24-year-old  nulli  -
gravida  woman  who  presented  with  acute
abdominal pain and was diagnosed with a rup-
ture of an ovarian chocolate cyst. Subsequent
surgery revealed that the tumor arose in the
uterus,  and  the  histological  diagnosis  was
uterine PEComa with low potential malignan-
cy.  Recurrent  PEComa  in  the  uterine  cervix
were excised twice, and she remains disease
free 12 months after the last operation. To the
best of our knowledge, this is the first report of
recurrent  cervical  PEComa  with  fertility-pre-
serving  surgery.  Estimating  the  malignant
potential and appropriate surgery are essential
for young patients with uterine PEComa.
Introduction
Perivascular  epithelioid  cell  tumors
(PEComa) are rare mesenchymal neoplasms
that include angiomyolipoma, lymphangiomyo  -
matosis, clear cell tumor of the lung (CCTL),
and a set of similar visceral and soft tissue
lesions that are all characterized by "perivas-
cular  epithelioid  cells"
1 concentrated  around
the tumor blood vessels. This particular sub-
group is very rare, and has been reported in
several organs such as the uterus, lung, kid-
ney, liver, small and large bowel, and prostate.
In  previous  reports  of  uterine  PEComa,  the
mean age of patients was 45 years old, the pre-
dominant location was the corpus, and most
patients were treated with hysterectomy. Only
four  cases  of  cervical  PEComa  have  been
reported.
2 Here, we report recurrent cervical
PEComa in a young woman treated with fertil-
ity-preserving operations.
Case Report
A 24-year-old Japanese nulligravida woman,
with no history of tuberous sclerosis, was diag-
nosed with an ovarian chocolate cyst and treat-
ed for three months with gonadotropin-releas-
ing hormone analogue (GnRHa). Five months
later, an emergency laparotomy was performed
under  a  preoperative  diagnosis  of  ruptured
ovarian cyst because of sudden severe abdom  -
inal pain and massive ascites. Bloody ascites
measured 700 mL; both ovaries were normal but
the uterus had a 4 cm myoma on the left dorsal
side. Membranous tissue similar to endometrio-
sis was removed from the surface of the uterus
and was diagnosed pathologically as PEComa. 
Four months after the operation, the patient
visited our hospital with suspected recurrent
PEComa. Magnetic resonance imaging (MRI)
demonstrated a 26¥50¥59 mm cyst behind the
uterus (Figure 1A), but the computed tomog  -
raphy  (CT)  scan  showed  no  metastasis.  A
laparotomy was performed under the diagnosis
of recurrent PEComa. The uterus had a flat
tumor 10 cm in diameter on the left side of the
cervix (Figure 1B), and marked bloody ascites
in the closed Douglas pouch. The tumor was
resected  and  histological  examination
revealed a spindle cell tumor with some epithe-
lioid cells. The tumor cells had round to oval
nuclei with small but prominent nucleoli, and
abundant eosino  philic cytoplasm (Figure 1C).
Infiltrating patterns of growth were observed,
showing  a  tongue-like  pattern  of  the  tumor
extending into the surrounding stroma and a
net-like  pattern  with  hyalinized  stroma.
Immunohisto  chemical staining showed tumor
cells strongly positive for HMB-45 (Figure 1D),
and partially or weakly positive for CD34 and
factor VIII. AE1/3, S-100, c-kit, smooth muscle
actin (SMA), desmin, CD31, and CD1a were
negative in the specimens tested. The prolifer-
ation marker MIB-1 was immunoreactive in 2-
3% of tumor cells. Therefore, this tumor was
diagnosed as recurrent PEComa of the uterine
cervix with low-grade malignancy. 
Seven months after the second operation,
the  patient  suffered  prolonged  menstrual
bleeding  and  slight  abdominal  pain.  MRI
revealed a 10¥14 mm defect in the left-side
wall of the uterine cervix and hemorrhage in
the Douglas pouch. A third laparotomy was per-
formed after GnRHa treatment for six months,
and a myometrial defect, 15 mm in diameter,
was found on the left side of the cervix. The
uterine  wall  was  sutured  after  debridement
and  the  resected  tissue  was  diagnosed
immunohistochemically as recurrent PEComa.
At the most recent follow-up 12 months later,
there was no evidence of recurrence.
Discussion
PEComa are characterized by an epithelioid
morphology,  clear  to  eosinophilic  granular
cytoplasm,  coexpression  of  smooth  muscle
(actin and/or desmin) and melanocytic mark-
ers (HMB-45 and/or melanA), and at least in
some  cases,  arrangement  around  blood  ves-
sels.
2,3 However,  in  our  case  tumor  cells
expressed  HMB-45  strongly,  but  no  smooth
muscle  markers.  Uterine  epithelioid  mes-
enchymal  tumors  composed  of  cells  that
expressed HMB-45 were classified as PEComa,
regardless of the absence or presence of mus-
cle markers
.2,4 The immunophenotypic profile
of the uterine PEComa showed that positivity
for SMA and desmin was not 100%, but greater
than 70% and almost half, respectivity.
2,4,5 Vang
et al.
4 divided PEComa of the uterus into two
groups  (A  and  B)  morphologically,  and  the
muscle marker expression was scanty in group
A but extensive in group B. These reports sug-
gested that PEComa are a subset of HMB-45
positive  epithelioid  mesenchymal  tumors  of
the uterus with an uncertain relationship to
pure smooth muscle tumors. 
It is important to distinguish PEComa from
other  mesenchymal  tumors.  In  most  cases,
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clear cell sarcomas can be distinguished from
PEComa by virtue of their strong expression of
S-100 protein and nonimmunoreactivity with
SMA.
1 It  was  reported  recently  that  CD1a
expression  may  be  a  useful  immunohisto-
chemical adjunct in the diagnosis of uterine
PEComa,  distinguishing  them  from  uterine
epithelioid smooth muscle tumors,
6,7 but our
case was negative for SMA as well as for CD1a.
For endothelial markers, the tumor cells in our
case were weakly or partially positive for CD34
and factor VIII, but negative for CD31. There
are only a few reports that showed the results
of immunoreactivity with CD34 in endothelial
markers, and CD34 positivity was seen in 5%
of the uterine PEComa cases.
5 Gastrointestinal
stromal tumors (GISTs) may also enter the dif-
ferential diagnosis of PEComa, as both tumors
show  a  mixture  of  epithelioid  and  spindled
morphology. CD34, which is positive in GISTs,
may be useful in this differential diagnosis.
1
However,  PEComa  differ  from  GISTs  in  that
they typically show clear to light eosinophilic
cytoplasm.  These  findings  suggest  that  the
diagnosis  of  PEComa  should  be  performed
comprehensively  with  morphological  and
immunophenotypical features.
Forty-six uterine PEComa cases had been
reported in the English literature by November
30, 2009;
2 however, 42 cases arose in the cor-
pus and four in the cervix,
1,8,9 and our case is
the fifth report of cervical PEComa (Table 1).
In  cervical  PEComa,  patients  were  younger
than  in  corpus  PEComa  cases  (cervical,
33.2±10.7; corpus, 45.3±14.7), with recurrence
occurring only in our case and no mortality
reported, whereas nine patients showed recur-
rence and four died in the 42 corpus PEComa
cases. However, cervical PEComa are so rare
that it cannot be determined whether the prog-
nosis of cervical PEComa is better than that of
corpus PEComa.
Our  case  recurred  twice  in  the  uterine
cervix, but the tumor was resected only to pre-
serve fertility. Three previously reported cer  -
vical PEComa were treated with hysterectomy,
and one with radiotherapy, possibly because
excision  is  more  difficult  for  tumors  of  the
cervix than of the corpus owing to their length
and location. In 46 uterine PEComa, four cor-
pus PEComa were treated only with excision,
and the outcomes of the three available cases
showed  that  one  had  recurrent  lymph  node
metastasis but all were cured. 
The malignant potential of PEComa varies
and this can be determined by mitotic activity,
cellularity, nuclear grade, etc.
1 Our case was
diagnosed as PEComa with low-grade malig-
nancy because the proliferation marker MIB-1
was immunoreactive in 2-3% of tumor cells.
The mitotic rate and labeling index for MIB-1
(Ki-67) are useful to determine the malignant
level, and fertility-sparing operations can be
considered for low malignant uterine PEComa.
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Case Report
Table 1. Reported cases of uterine cervical perivascular epithelioid cell tumors.
Case Age History of  Management Malignancy Outcome Reference
pregnancy
1 28 NS Hysterectomy,  MI 0/50HPF NED 36 m 1
lymphadenectomy
2 48 NS Adjuvant radiotherapy MI 0/50HPF NED 21 m 1
3 25 Multiparous Radical hysterectomy,  NS NS 8
lymphadenectomy
4 41 Gravid-1 Hysterectomy, BSO MI <1/50HPF NED 35 m 9
Para-1
5 24 Null Excision MIB-1 2-3% Recurrence 4 m  Present
and 11 m, NED 12 m
NS, not stated; MI, mitotic index; NED, no evidence of disease; BSO, bilateral salpingo-oophorectomy.
Figure 1. (A) T2-weighted
MRI of the pelvis demon-
strated a hemorrhage cyst
from  the  uterine  cervix.
(B)  Gross  appearance  of
the tumor was flat, thick,
and  smooth-surfaced.
Scale  bar  =  2  cm.  (C)
Histological  appearance
of  the  tumor  showing  a
spindle  cell  tumor  with
round, swollen nuclei and
abundant  eosinophilic
cytoplasm  (hematoxylin
and eosin stain; magnifi-
cation: 100X). (D) Strong
reaction  of  the  tumor
cells with the melanocytic
marker HMB-45 (magni-
fication: 100X).
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